Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03247335 · ClinicalTrials.gov registry record

Follow-up of Arthrosurface HemiCAP Implants

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
75
Enrollment target

NCT03247335: Completed study, sponsored by The Cleveland Clinic.

NCT03247335 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03247335 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
75 participants
Enrollment target

Study Summary

Follow-up of Arthrosurface HemiCAP shoulder implants.

Primary Outcome

survival curve for the implant

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2018-01-31
Est. Completion 2019-08-01
The Cleveland Clinic

688 total trials

What the finished NCT03247335 record still lists

NCT03247335 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT03247335 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03247335 about?

NCT03247335 is a clinical study titled "Follow-up of Arthrosurface HemiCAP Implants". Follow-up of Arthrosurface HemiCAP shoulder implants.

What is the current status of trial NCT03247335?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2018-01-31. Estimated completion is 2019-08-01.

Who is sponsoring clinical trial NCT03247335?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03247335, the US trial registry maintained by the National Library of Medicine. NCT03247335 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.